Announcements

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of artificial intelligence in cancer, which are listed below:

1. “Exploring the Potential Role of Upper Abdominal Peritonectomy in Advanced Ovarian Cancer Cytoreductive Surgery Using Explainable Artificial Intelligence”
by Alexandros Laios, Evangelos Kalampokis, Marios Evangelos Mamalis, Amudha Thangavelu, Richard Hutson, Tim Broadhead, David Nugent and Diederick De Jong
Cancers 2023, 15(22), 5386; https://doi.org/10.3390/cancers15225386
Available online: https://www.mdpi.com/2072-6694/15/22/5386

2. “Artificial Intelligence-Based Hazard Detection in Robotic-Assisted Single-Incision Oncologic Surgery”
by Gabriela Rus, Iulia Andras, Calin Vaida, Nicolae Crisan, Bogdan Gherman, Corina Radu, Paul Tucan, Stefan Iakab, Nadim Al Hajjar and Doina Pisla
Cancers 2023, 15(13), 3387; https://doi.org/10.3390/cancers15133387
Available online: https://www.mdpi.com/2072-6694/15/13/3387

3. “Optical Biopsy of Dysplasia in Barrett’s Oesophagus Assisted by Artificial Intelligence”
by Jouke J. H. van der Laan, Joost A. van der Putten, Xiaojuan Zhao, Arend Karrenbeld, Frans T. M. Peters, Jessie Westerhof, Peter H. N. de With, Fons van der Sommen and Wouter B. Nagengast
Cancers 2023, 15(7), 1950; https://doi.org/10.3390/cancers15071950
Available online: https://www.mdpi.com/2072-6694/15/7/1950

4. “An Interpretable Three-Dimensional Artificial Intelligence Model for Computer-Aided Diagnosis of Lung Nodules in Computed Tomography Images”
by Sheng-Chieh Hung, Yao-Tung Wang and Ming-Hseng Tseng
Cancers 2023, 15(18), 4655; https://doi.org/10.3390/cancers15184655
Available online: https://www.mdpi.com/2072-6694/15/18/4655

5. “A Novel Approach for Estimating Ovarian Cancer Tissue Heterogeneity through the Application of Image Processing Techniques and Artificial Intelligence”
by Dimitrios A. Binas, Petros Tzanakakis, Theodore L. Economopoulos, Marianna Konidari, Charis Bourgioti, Lia Angela Moulopoulos and George K. Matsopoulos
Cancers 2023, 15(4), 1058; https://doi.org/10.3390/cancers15041058
Available online: https://www.mdpi.com/2072-6694/15/4/1058

6. “Clinical Use of a Commercial Artificial Intelligence-Based Software for Autocontouring in Radiation Therapy: Geometric Performance and Dosimetric Impact”
by S M Hasibul Hoque, Giovanni Pirrone, Fabio Matrone, Alessandra Donofrio, Giuseppe Fanetti, Angela Caroli, Rahnuma Shahrin Rista, Roberto Bortolus, Michele Avanzo, Annalisa Drigo et al.
Cancers 2023, 15(24), 5735; https://doi.org/10.3390/cancers15245735
Available online: https://www.mdpi.com/2072-6694/15/24/5735

7. “The Development and External Validation of Artificial Intelligence-Driven MRI-Based Models to Improve Prediction of Lesion-Specific Extraprostatic Extension in Patients with Prostate Cancer”
by Ingeborg van den Berg, Timo F. W. Soeterik, Erik J. R. J. van der Hoeven, Bart Claassen, Wyger M. Brink, Diederik J. H. Baas, J. P. Michiel Sedelaar, Lizette Heine, Jim Tol, Jochem R. N. van der Voort van Zyp et al.
Cancers 2023, 15(22), 5452; https://doi.org/10.3390/cancers15225452
Available online: https://www.mdpi.com/2072-6694/15/22/5452

8. “A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence”
by James Moroney, Juan Trivella, Ben George and Sarah B. White
Cancers 2023, 15(10), 2791; https://doi.org/10.3390/cancers15102791
Available online: https://www.mdpi.com/2072-6694/15/10/2791

9. “Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma”
by Joanna Jiang, Wei-Lun Chao, Stacey Culp and Somashekar G. Krishna
Cancers 2023, 15(9), 2410; https://doi.org/10.3390/cancers15092410
Available online: https://www.mdpi.com/2072-6694/15/9/2410

10. “Artificial Intelligence in Urooncology: What We Have and What We Expect”
by Anita Froń, Alina Semianiuk, Uladzimir Lazuk, Kuba Ptaszkowski, Agnieszka Siennicka, Artur Lemiński, Wojciech Krajewski, Tomasz Szydełko and Bartosz Małkiewicz
Cancers 2023, 15(17), 4282; https://doi.org/10.3390/cancers15174282
Available online: https://www.mdpi.com/2072-6694/15/17/4282

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the Section “Cancer Informatics and Big Data”, which are listed below.

1. “Predicting Chemotherapy Benefit across Different Races in Early-Stage Breast Cancer Patients Using the Oncotype DX Score”
by Vikram R. Shaw, Christopher I. Amos and Chao Cheng
Cancers 2023, 15(12), 3217; https://doi.org/10.3390/cancers15123217
Available online: https://www.mdpi.com/2072-6694/15/12/3217

2. “Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis”
by Saniya Arfin, Dhruv Kumar, Andrea Lomagno, Pietro Luigi Mauri and Dario Di Silvestre
Cancers 2023, 15(17), 4420; https://doi.org/10.3390/cancers15174420
Available online: https://www.mdpi.com/2072-6694/15/17/4420

3. “Efficient Convolution Network to Assist Breast Cancer Diagnosis and Target Therapy”
by Ching-Wei Wang, Kai-Lin Chu, Hikam Muzakky, Yi-Jia Lin and Tai-Kuang Chao
Cancers 2023, 15(15), 3991; https://doi.org/10.3390/cancers15153991
Available online: https://www.mdpi.com/2072-6694/15/15/3991

4. “Vessel Delineation Using U-Net: A Sparse Labeled Deep Learning Approach for Semantic Segmentation of Histological Images”
by Lukas Glänzer, Husam E. Masalkhi, Anjali A. Roeth, Thomas Schmitz-Rode and Ioana Slabu
Cancers 2023, 15(15), 3773; https://doi.org/10.3390/cancers15153773
Available online: https://www.mdpi.com/2072-6694/15/15/3773

5. “Machine Learning for Digital Scoring of PRMT6 in Immunohistochemical Labeled Lung Cancer”
by Abeer M. Mahmoud, Eileen Brister, Odile David, Klara Valyi-Nagy, Maria Sverdlov, Peter H. Gann and Sage J. Kim
Cancers 2023, 15(18), 4582; https://doi.org/10.3390/cancers15184582
Available online: https://www.mdpi.com/2072-6694/15/18/4582

6. “Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy”
by Roma Raj, Chase J. Wehrle, Nihal Aykun, Henry Stitzel, Wen Wee Ma, Smitha Krishnamurthi, Bassam Estfan, Suneel Kamath, David C. H. Kwon and Federico Aucejo
Cancers 2023, 15(21), 5220; https://doi.org/10.3390/cancers15215220
Available online: https://www.mdpi.com/2072-6694/15/21/5220

7. “Deep Learning for the Pathologic Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer”
by Hyun-Jong Jang, Jai-Hyang Go, Younghoon Kim and Sung Hak Lee
Cancers 2023, 15(22), 5389; https://doi.org/10.3390/cancers15225389
Available online: https://www.mdpi.com/2072-6694/15/22/5389

8. “Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer”
by Ran Song, Dong-Eun Lee, Eun-Gyeong Lee, Seeyoun Lee, Han-Sung Kang, Jai Hong Han, Keun Seok Lee, Sung Hoon Sim, Heejung Chae, Youngmee Kwon et al.
Cancers 2023, 15(18), 4451; https://doi.org/10.3390/cancers15184451
Available online: https://www.mdpi.com/2072-6694/15/18/4451

9. “3DGAUnet: 3D Generative Adversarial Networks with a 3D U-Net Based Generator to Achieve the Accurate and Effective Synthesis of Clinical Tumor Image Data for Pancreatic Cancer”
by Yu Shi, Hannah Tang, Michael J. Baine, Michael A. Hollingsworth, Huijing Du, Dandan Zheng, Chi Zhang and Hongfeng Yu
Cancers 2023, 15(23), 5496; https://doi.org/10.3390/cancers15235496
Available online: https://www.mdpi.com/2072-6694/15/23/5496

10. “Predicting Lymph Node Metastasis Status from Primary Muscle-Invasive Bladder Cancer Histology Slides Using Deep Learning: A Retrospective Multicenter Study”
by Qingyuan Zheng, Jun Jian, Jingsong Wang, Kai Wang, Junjie Fan, Huazhen Xu, Xinmiao Ni, Song Yang, Jingping Yuan, Jiejun Wu et al.
Cancers 2023, 15(11), 3000; https://doi.org/10.3390/cancers15113000
Available online: https://www.mdpi.com/2072-6694/15/11/3000

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in 2023 in the Section “Pediatric Oncology”, which are listed below:

1. “Evaluation of Potential Targets for Fluorescence-Guided Surgery in Pediatric Ewing Sarcoma: A Preclinical Proof-of-Concept Study”
by Bernadette Jeremiasse, Zeger Rijs, Karieshma R. Angoelal, Laura S. Hiemcke-Jiwa, Ella A. de Boed, Peter J. K. Kuppen, Cornelis F. M. Sier, Pieter B. A. A. van Driel, Michiel A. J. van de Sande, Marc H. W. A. Wijnen et al.
Cancers 2023, 15(15), 3896; https://doi.org/10.3390/cancers15153896
Available online: https://www.mdpi.com/2072-6694/15/15/3896

2. “Epidemiology and Characteristics of Gastric Carcinoma in Childhood—An Analysis of Data from Population-Based and Clinical Cancer Registries”
by Michael Abele, Lisa Grabner, Tabea Blessing, Andreas Block, Abbas Agaimy, Christian Kratz, Thorsten Simon, Gabriele Calaminus, Sabine Heine, Selim Corbacioglu et al.
Cancers 2023, 15(1), 317; https://doi.org/10.3390/cancers15010317
Available online: https://www.mdpi.com/2072-6694/15/1/317

3. “Pediatric Extracranial Germ Cell Tumors: Review of Clinics and Perspectives in Application of Autologous Stem Cell Transplantation”
by Chong-Zhi Lew, Hsi-Che Liu, Jen-Yin Hou, Ting-Huan Huang and Ting-Chi Yeh
Cancers 2023, 15(7), 1998; https://doi.org/10.3390/cancers15071998
Available online: https://www.mdpi.com/2072-6694/15/7/1998

4. “Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR”
by Natalia Stepien, Daniel Senfter, Julia Furtner, Christine Haberler, Christian Dorfer, Thomas Czech, Daniela Lötsch-Gojo, Lisa Mayr, Cora Hedrich, Alicia Baumgartner et al.
Cancers 2023, 15(9), 2525; https://doi.org/10.3390/cancers15092525
Available online: https://www.mdpi.com/2072-6694/15/9/2525

5. “Impact of Time to Surgery on Outcome in Wilms Tumor Treated with Preoperative Chemotherapy”
by Clemens-Magnus Meier, Rhoikos Furtwängler, Marvin Mergen, Nils Welter, Patrick Melchior, Jens-Peter Schenk, Christian Vokuhl, Leo Kager, Sabine Kroiss-Benninger, Stefan Wagenpfeil et al.
Cancers 2023, 15(5), 1494; https://doi.org/10.3390/cancers15051494
Available online: https://www.mdpi.com/2072-6694/15/5/1494

6. “Proton Therapy for Advanced Juvenile Nasopharyngeal Angiofibroma”
by Line Hoeltgen, Thomas Tessonnier, Eva Meixner, Philipp Hoegen, Ji-Young Kim, Maximilian Deng, Katharina Seidensaal, Thomas Held, Klaus Herfarth, Juergen Debus et al.
Cancers 2023, 15(20), 5022; https://doi.org/10.3390/cancers15205022
Available online: https://www.mdpi.com/2072-6694/15/20/5022

7. “Integrative Transcriptomic Profiling of the Wilms Tumor”
by Simona Lucija Avčin, Klementina Črepinšek, Barbara Jenko Bizjan, Robert Šket, Jernej Kovač, Blaž Vrhovšek, Jerca Blazina, Olga Blatnik, Robert Kordič, Lidija Kitanovski et al.
Cancers 2023, 15(15), 3846; https://doi.org/10.3390/cancers15153846
Available online: https://www.mdpi.com/2072-6694/15/15/3846

8. “Pediatric Atypical Melanocytic Proliferations: Single-Site Retrospective Cohort Assessment of Treatment and Long-Term Follow-Up”
by Emily Hatheway Marshall, Gabriella Alvarez, Bangchen Wang, Jennifer Crimmins, Michelle M. Schneider, M. Angelica Selim and Rami N. Al-Rohil
Cancers 2023, 15(24), 5804; https://doi.org/10.3390/cancers15245804
Available online: https://www.mdpi.com/2072-6694/15/24/5804

9. “Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia”
by Emma J. Verwaaijen, Patrick van der Torre, Josef Vormoor, Rob Pieters, Marta Fiocco, Annelies Hartman and Marry M. van den Heuvel-Eibrink
Cancers 2023, 15(1), 320; https://doi.org/10.3390/cancers15010320
Available online: https://www.mdpi.com/2072-6694/15/1/320

10. “Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development”
by Ye Yuan, Mohammad Alzrigat, Aida Rodriguez-Garcia, Xueyao Wang, Tomas Sjöberg Bexelius, John Inge Johnsen, Marie Arsenian-Henriksson, Judit Liaño-Pons and Oscar C. Bedoya-Reina
Cancers 2023, 15(18), 4599; https://doi.org/10.3390/cancers15184599
Available online: https://www.mdpi.com/2072-6694/15/18/4599

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of diagnosis and treatment of bladder cancer, which are listed below.

1. “Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry”
by Christoph Pöttgen, Christian Hoffmann, Thomas Gauler, Maja Guberina, Nika Guberina, Toke Ringbaek, Alina Santiago Garcia, Ulrich Krafft, Boris Hadaschik, Aymane Khouya et al.
Cancers 2023, 15(20), 4933; https://doi.org/10.3390/cancers15204933
Available online: https://www.mdpi.com/2072-6694/15/20/4933

2. “Genomic Biomarker Discovery in Disease Progression and Therapy Response in Bladder Cancer Utilizing Machine Learning”
by Konstantinos Christos Liosis, Ahmed Al Marouf, Jon G. Rokne, Sunita Ghosh, Tarek A. Bismar and Reda Alhajj
Cancers 2023, 15(19), 4801; https://doi.org/10.3390/cancers15194801
Available online: https://www.mdpi.com/2072-6694/15/19/4801

3. “Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder Cancer”
by Aymane Khouya, Christoph Pöttgen, Christian Hoffmann, Toke Printz Ringbaek, Wolfgang Lübcke, Frank Indenkämpen, Maja Guberina, Nika Guberina, Thomas Gauler, Martin Stuschke et al.
Cancers 2023, 15(23), 5629; https://doi.org/10.3390/cancers15235629
Available online: https://www.mdpi.com/2072-6694/15/23/5629

4. “Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder Cancer”
by Oguz Akin, Alfonso Lema-Dopico, Ramesh Paudyal, Amaresha Shridhar Konar, Thomas L. Chenevert, Dariya Malyarenko, Lubomir Hadjiiski, Hikmat Al-Ahmadie, Alvin C. Goh, Bernard Bochner et al.
Cancers 2023, 15(22), 5468; https://doi.org/10.3390/cancers15225468
Available online: https://www.mdpi.com/2072-6694/15/22/5468

5. “Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis”
by Amélie Aboudaram, Léonor Chaltiel, Damien Pouessel, Pierre Graff-Cailleaud, Nicolas Benziane-Ouaritini, Paul Sargos, Ulrike Schick, Gilles Créhange, Elizabeth Cohen-Jonathan Moyal, Christine Chevreau et al.
Cancers 2023, 15(4), 1161; https://doi.org/10.3390/cancers15041161
Available online: https://www.mdpi.com/2072-6694/15/4/1161

6. “Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial”
by Stéphane Culine, Valentin Harter, Clémentine Krucker, Gwenaelle Gravis, Aude Fléchon, Christine Chevreau, Hakim Mahammedi, Brigitte Laguerre, Aline Guillot, Florence Joly et al.
Cancers 2023, 15(6), 1742; https://doi.org/10.3390/cancers15061742
Available online: https://www.mdpi.com/2072-6694/15/6/1742

7. “Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival”
by Hubert Kamecki, Małgorzata Dębowska, Jan Poleszczuk, Tomasz Demkow, Artur Przewor, Łukasz Nyk and Roman Sosnowski
Cancers 2023, 15(3), 668; https://doi.org/10.3390/cancers15030668
Available online: https://www.mdpi.com/2072-6694/15/3/668

8. “Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer”
by Makito Miyake, Nobutaka Nishimura, Sayuri Ohnishi, Yuki Oda, Takuya Owari, Kenta Ohnishi, Yosuke Morizawa, Shunta Hori, Daisuke Gotoh, Yasushi Nakai et al.
Cancers 2023, 15(9), 2565; https://doi.org/10.3390/cancers15092565
Available online: https://www.mdpi.com/2072-6694/15/9/2565

9. “Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis”
by Evie Papavasiliou, Valerie A. Sills, Natalia Calanzani, Hannah Harrison, Claudia Snudden, Erica di Martino, Andy Cowan, Dawnya Behiyat, Rachel Boscott, Sapphire Tan et al.
Cancers 2023, 15(3), 709; https://doi.org/10.3390/cancers15030709
Available online: https://www.mdpi.com/2072-6694/15/3/709

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of diagnostic biomarkers of ovarian cancer, which are listed below:

1. “Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1”
by Yvonne Grobben, Judith E. den Ouden, Cristina Aguado, Anne M. van Altena, Aletta D. Kraneveld and Guido J. R. Zaman
Cancers 2023, 15(3), 893; https://doi.org/10.3390/cancers15030893
Available online: https://doi.org/10.3390/cancers15030893

2. “Identification and Characterization of Aptamers Targeting Ovarian Cancer Biomarker Human Epididymis Protein 4 for the Application in Urine”
by Antonija Hanžek, Frédéric Ducongé, Christian Siatka and Anne-Cécile E. Duc
Cancers 2023, 15(2), 452; https://doi.org/10.3390/cancers15020452
Available online: https://doi.org/10.3390/cancers15020452

3. “Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets”
by Julia Oto, Quang-Khoi Le, Sebastian D. Schäfer, Ludwig Kiese, Josep Marí-Alexandre, Juan Gilabert-Estellés, Pilar Medina and Martin Götte
Cancers 2023, 15(12), 3125; https://doi.org/10.3390/cancers15123125
Available online: https://doi.org/10.3390/cancers15123125

4. “Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers”
by Vikneswary Ravi Kumar, Nirmala Chandralega Kampa, Nor Haslinda Abd Aziz, Chew Kah Teik, Mohamad Nasir Shafiee and P. Susthitha Menon
Cancers 2023, 15(23), 5607; https://doi.org/10.3390/cancers15235607
Available online: https://doi.org/10.3390/cancers15235607

5. “Glucose-Regulated Protein 78 Is a Potential Serum and Imaging Marker for Early Detection of Ovarian Cancer”
by Elizabeth A. Paris, Janice M. Bahr, Jacques S. Abramowicz, Sanjib Basu and Animesh Barua
Cancers 2023, 15(4), 1140; https://doi.org/10.3390/cancers15041140
Available online: https://doi.org/10.3390/cancers15041140

6. “Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women”
by Chloe E. Barr, Kelechi Njoku, Gemma L. Owens and Emma J. Crosbie
Cancers 2023, 15(4), 1256; https://doi.org/10.3390/cancers15041256
Available online: https://doi.org/10.3390/cancers15041256

7. “A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer”
by Andrew N. Stephens, Simon J. Hobbs, Sung-Woon Kang, Maree Bilandzic, Adam Rainczuk, Martin K. Oehler, Tom W. Jobling, Magdalena Plebanski and Richard Allman
Cancers 2023, 15(21), 5267; https://doi.org/10.3390/cancers15215267
Available online: https://doi.org/10.3390/cancers15215267

8. “The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition”
by Graziana Scavone, Silvia Ottonello, Eva Blondeaux, Luca Arecco, Paola Scaruffi, Sara Stigliani, Barbara Cardinali, Roberto Bore, Michele Paudice, Valerio G. Vellone et al.
Cancers 2023, 15(20), 4923; https://doi.org/10.3390/cancers15204923
Available online: https://doi.org/10.3390/cancers15204923

9. “PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer”
by Henriett Butz, Petra Nagy, János Papp, Anikó Bozsik, Vince Kornél Grolmusz, Tímea Pócza, Edit Oláh and Attila Patócs
Cancers 2023, 15(17), 4350; https://doi.org/10.3390/cancers15174350
Available online: https://doi.org/10.3390/cancers15174350

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of metabolic reprogramming in the tumor microenvironment, which are listed below:

1. “A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages”
by Iseulys Richert, Paul Berchard, Lhorra Abbes, Alexey Novikov, Kamel Chettab, Alexandra Vandermoeten, Charles Dumontet, Marie Karanian, Jerome Kerzerho, Martine Caroff et al.
Cancers 2023, 15(18), 4635; https://doi.org/10.3390/cancers15184635
Available online: https://www.mdpi.com/2072-6694/15/18/4635

2. “Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy”
by Julieta Afonso, Céline Gonçalves, Marta Costa, Débora Ferreira, Lúcio Santos, Adhemar Longatto-Filho and Fátima Baltazar
Cancers 2023, 15(3), 982; https://doi.org/10.3390/cancers15030982
Available online: https://www.mdpi.com/2072-6694/15/3/982

3. “Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming”
by Maria Alvanou, Memnon Lysandrou, Panayota Christophi, Nikoleta Psatha, Alexandros Spyridonidis, Anastasia Papadopoulou and Evangelia Yannaki
Cancers 2023, 15(7), 1935; https://doi.org/10.3390/cancers15071935
Available online: https://www.mdpi.com/2072-6694/15/7/1935

4. “Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification”
by Jyotirmayee Talapatra and Mamatha M. Reddy
Cancers 2023, 15(7), 2144; https://doi.org/10.3390/cancers15072144
Available online: https://www.mdpi.com/2072-6694/15/7/2144

5. “Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance”
by Pan Lei, Wenzhou Wang, Marisela Sheldon, Yutong Sun, Fan Yao and Li Ma
Cancers 2023, 15(13), 3390; https://doi.org/10.3390/cancers15133390
Available online: https://www.mdpi.com/2072-6694/15/13/3390

6. “Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies”
by Constantinos Savva, Ellen Copson, Peter W. M. Johnson, Ramsey I. Cutress and Stephen A. Beers
Cancers 2023, 15(9), 2440; https://doi.org/10.3390/cancers15092440
Available online: https://www.mdpi.com/2072-6694/15/9/2440

7. “Reprogramming of the Genome-Wide DNA Methylation Landscape in Three-Dimensional Cancer Cell Cultures”
by Alma Jaqueline Heredia-Mendez, Gricelda Sánchez-Sánchez and César López-Camarillo
Cancers 2023, 15(7), 1991; https://doi.org/10.3390/cancers15071991
Available online: https://www.mdpi.com/2072-6694/15/7/1991

8. “Intestinal Epithelial Cells Adapt to Chronic Inflammation through Partial Genetic Reprogramming”
by Guillaume Collin, Jean-Philippe Foy, Nicolas Aznar, Nicolas Rama, Anne Wierinckx, Pierre Saintigny, Alain Puisieux and Stéphane Ansieau
Cancers 2023, 15(3), 973; https://doi.org/10.3390/cancers15030973
Available online: https://www.mdpi.com/2072-6694/15/3/973

9. “Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus”
by Tong Yu, Archana Chandrabhan Jadhav, Jiabao Xu, Adrian L. Harris, Venugopal Nair and Wei E. Huang
Cancers 2023, 15(3), 811; https://doi.org/10.3390/cancers15030811
Available online: https://www.mdpi.com/2072-6694/15/3/811

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers on the subject of the microbiome and cancer, which are listed below:

1. “The Role of Blood Microbiome in the Development of Thyroid Cancer in Breast Cancer Survivors”
by Jeongshin An, Hyungju Kwon and Young Ju Kim
Cancers 2023, 15(18), 4492; https://doi.org/10.3390/cancers15184492
Available online: https://www.mdpi.com/2072-6694/15/18/4492

2. “The Influence of the Microbiome on Urological Malignancies: A Systematic Review”
by Joao G. Porto, Maria Camila Suarez Arbelaez, Brandon Pena, Archan Khandekar, Ankur Malpani, Bruno Nahar, Sanoj Punnen, Chad R. Ritch, Mark L. Gonzalgo, Dipen J. Parekh et al.
Cancers 2023, 15(20), 4984; https://doi.org/10.3390/cancers15204984
Available online: https://www.mdpi.com/2072-6694/15/20/4984

3. “Oral Microbiome Community Composition in Head and Neck Squamous Cell Carcinoma”
by William J. Benjamin, Kai Wang, Katherine Zarins, Emily Bellile, Freida Blostein, Ilona Argirion, Jeremy M. G. Taylor, Nisha J. D’Silva, Steven B. Chinn Samara Rifkin et al.
Cancers 2023, 15(9), 2549; https://doi.org/10.3390/cancers15092549
Available online: https://www.mdpi.com/2072-6694/15/9/2549

4. “Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein–Barr Virus”
by Wing Sum Shin, Fuda Xie, Bonan Chen, Jun Yu, Kwok Wai Lo, Gary M. K. Tse, Ka Fai To and Wei Kang
Cancers 2023, 15(20), 4993; https://doi.org/10.3390/cancers15204993
Available online: https://www.mdpi.com/2072-6694/15/20/4993

5. “Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies?”
by James M. Halle-Smith, Lewis A. Hall, Sarah F. Powell-Brett, Nabeel Merali, Adam E. Frampton, Andrew D. Beggs, Paul Moss and Keith J. Roberts
Cancers 2023, 15(21), 5140; https://doi.org/10.3390/cancers15215140
Available online: https://www.mdpi.com/2072-6694/15/21/5140

6. “Host Microbiomes Influence the Effects of Diet on Inflammation and Cancer”
by Ramsha Mahmood, Athalia Voisin, Hana Olof, Reihane Khorasaniha, Samuel A. Lawal and Heather K. Armstrong
Cancers 2023, 15(2), 521; https://doi.org/10.3390/cancers15020521
Available online:  https://doi.org/10.3390/cancers15020521

7. “Fecal Microbiota Restoration Modulates the Microbiome in Inflammation-Driven Colorectal Cancer”
by Travis J Gates, Ce Yuan, Mihir Shetty, Thomas Kaiser, Andrew C Nelson, Aastha Chauhan, Timothy K Starr, Christopher Staley and Subbaya Subramanian
Cancers 2023, 15(8), 2260; https://doi.org/10.3390/cancers15082260
Available online: https://doi.org/10.3390/cancers15082260

8. “Evaluation of the Oesophagogastric Cancer-Associated Microbiome: A Systematic Review and Quality Assessment”
by Bhamini Vadhwana, Munir Tarazi, Piers R. Boshier and George B. Hanna
Cancers 2023, 15(10), 2668; https://doi.org/10.3390/cancers15102668
Available online: https://doi.org/10.3390/cancers15102668

9. “Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing”
by Zoe Welham, Jun Li, Alexander F. Engel and Mark P. Molloy
Cancers 2023, 15(20), 5045; https://doi.org/10.3390/cancers15205045
Available online: https://doi.org/10.3390/cancers15205045

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers from 2023 in the field of breast cancer survivorship, which are listed below:

1. “Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways”
by Mariella Schneider, Melitta B. Köpke, Alaleh Zati zehni, Theresa Vilsmaier, Mirjana Kessler, Magdalena Kailuweit, Aurelia Vattai, Helene Hildegard Heidegger, Vincent Cavaillès, Udo Jeschke et al.
Cancers 2023, 15(14), 3610; https://doi.org/10.3390/cancers15143610
Available online: https://www.mdpi.com/2072-6694/15/14/3610

2. “SaBrcada: Survival Intervals Prediction for Breast Cancer Patients by Dimension Raising and Age Stratification”
by Shih-Huan Lin, Ching-Hsuan Chien, Kai-Po Chang, Min-Fang Lu, Yu-Ting Chen and Yen-Wei Chu
Cancers 2023, 15(14), 3690; https://doi.org/10.3390/cancers15143690
Available online: https://www.mdpi.com/2072-6694/15/14/3690

3. “Presence of Multi-Morbidities and Colorectal Cancer Screening Utilization among Breast Cancer Survivors”
by Meng-Han Tsai, Caitlyn Grunert, Jacqueline B. Vo, Justin X. Moore and Avirup Guha
Cancers 2023, 15(7), 2077; https://doi.org/10.3390/cancers15072077
Available online: https://www.mdpi.com/2072-6694/15/7/2077

4. “Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery”
by Gilles Houvenaeghel, Monique Cohen, Marc Martino, Fabien Reyal, Jean-Marc Classe, Marie-Pierre Chauvet, Pierre-Emmanuel Colombo, Mellie Heinemann, Eva Jouve, Pierre Gimbergues et al.
Cancers 2023, 15(18), 4567; https://doi.org/10.3390/cancers15184567
Available online: https://www.mdpi.com/2072-6694/15/18/4567

5. “Proteomic Profile Distinguishes New Subpopulations of Breast Cancer Patients with Different Survival Outcomes”
by Joanna Tobiasz and Joanna Polanska
Cancers 2023, 15(17), 4230; https://doi.org/10.3390/cancers15174230
Available online: https://www.mdpi.com/2072-6694/15/17/4230

6. “Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer”
by Huijun Zhao, Gregory Pond, Demetrios Simos, Zhou Wang, Susan Robertson, Gurmit Singh, Lisa Vandermeer, Mark Clemons and Christina Lynn Addison
Cancers 2023, 15(3), 571; https://doi.org/10.3390/cancers15030571
Available online: https://www.mdpi.com/2072-6694/15/3/571

7. “Cognitive Aging in Older Breast Cancer Survivors”
by James C. Root, Yuelin Li, Elizabeth Schofield, Irene Orlow, Elizabeth Ryan, Tiffany Traina, Sunita K. Patel and Tim A. Ahles
Cancers 2023, 15(12), 3208; https://doi.org/10.3390/cancers15123208
Available online: https://www.mdpi.com/2072-6694/15/12/3208

8. “Randomized Trial Evaluating a Self-Guided Lifestyle Intervention Delivered via Evidence-Based Materials versus a Waitlist Group on Changes in Body Weight, Diet Quality, Physical Activity, and Quality of Life among Breast Cancer Survivors”
by Leah S. Puklin, Maura Harrigan, Brenda Cartmel, Tara Sanft, Linda Gottlieb, Bin Zhou, Leah M. Ferrucci, Fang-Yong Li, Donna Spiegelman, Mona Sharifi et al.
Cancers 2023, 15(19), 4719; https://doi.org/10.3390/cancers15194719
Available online: https://www.mdpi.com/2072-6694/15/19/4719

9. “Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer”
by Ji-Yeon Kim, Junghoon Shin, Jin Seok Ahn, Yeon Hee Park and Young-Hyuck Im
Cancers 2023, 15(13), 3431; https://doi.org/10.3390/cancers15133431
Available online: https://www.mdpi.com/2072-6694/15/13/3431

10. “Inhibition of Dipeptidyl Peptidase-4 Activates Autophagy to Promote Survival of Breast Cancer Cells via the mTOR/HIF-1α Pathway”
by Emi Kawakita, Fan Yang, Sen Shi, Yuta Takagaki, Daisuke Koya and Keizo Kanasaki
Cancers 2023, 15(18), 4529; https://doi.org/10.3390/cancers15184529
Available online: https://www.mdpi.com/2072-6694/15/18/4529

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers. 

Cancers Editorial Office

We are pleased to invite you to read the notable papers in the field of lung cancer chemotherapy in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant papers is provided below.

“Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)”
by Wonjun Ji, In-Jae Oh, Cheol-Kyu Park, Sung Yong Lee, Juwhan Choi, Jae Cheol Lee, Jiwon Kim and Seung Hyeun Lee
Cancers 2023, 15(23), 5568; https://doi.org/10.3390/cancers15235568
Available online: https://www.mdpi.com/2072-6694/15/23/5568

“PD-1/PD-L1 Inhibitors plus Chemotherapy Versus Chemotherapy Alone for Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
by Eric Pasqualotto, Francisco Cezar Aquino de Moraes, Matheus Pedrotti Chavez, Maria Eduarda Cavalcanti Souza, Anna Luíza Soares de Oliveira Rodrigues, Rafael Oliva Morgado Ferreira, Lucca Moreira Lopes, Artur Menegaz de Almeida, Marianne Rodrigues Fernandes and Ney Pereira Carneiro dos Santos
Cancers 2023, 15(21), 5143; https://doi.org/10.3390/cancers15215143
Available online: https://www.mdpi.com/2072-6694/15/21/5143

“Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study”
by Keiko Tanimura, Takayuki Takeda, Akihiro Yoshimura, Ryoichi Honda, Shiho Goda, Shinsuke Shiotsu, Mototaka Fukui, Yusuke Chihara, Kiyoaki Uryu, Shota Takei et al.
Cancers 2023, 15(17), 4358; https://doi.org/10.3390/cancers15174358
Available online: https://www.mdpi.com/2072-6694/15/17/4358

“Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study”
by Takayuki Takeda, Tadaaki Yamada, Yusuke Kunimatsu, Keiko Tanimura, Kenji Morimoto, Shinsuke Shiotsu, Yusuke Chihara, Asuka Okada, Shigeto Horiuchi, Makoto Hibino et al.
Cancers 2023, 15(5), 1543; https://doi.org/10.3390/cancers15051543
Available online: https://www.mdpi.com/2072-6694/15/5/1543

“The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review”
by Shehab Mohamed, Luca Bertolaccini, Domenico Galetta, Francesco Petrella, Monica Casiraghi, Filippo de Marinis and Lorenzo Spaggiari
Cancers 2023, 15(9), 2476; https://doi.org/10.3390/cancers15092476
Available online: https://www.mdpi.com/2072-6694/15/9/2476

“First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study”
by Keiko Tanimura, Takayuki Takeda, Nobutaka Kataoka, Akihiro Yoshimura, Kentaro Nakanishi, Yuta Yamanaka, Hiroshige Yoshioka, Ryoichi Honda, Kiyoaki Uryu and Mototaka Fukui
Cancers 2023, 15(20), 4988; https://doi.org/10.3390/cancers15204988
Available online: https://www.mdpi.com/2072-6694/15/20/4988

“Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy”
by Miriam Möller, Wolfgang Schütte, Steffi Turzer, Barbara Seliger and Dagmar Riemann
Cancers 2023, 15(19), 4873; https://doi.org/10.3390/cancers15194873
Available online: https://www.mdpi.com/2072-6694/15/19/4873

“Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 Expression”
by Beung-Chul Ahn, Charny Park, Sang-Jin Lee, Sehwa Hong, Ji-Eun Hwang, Kyoungsuk Kwon, Jin Young Kim, Kyung-Hee Kim, Hyae Young Kim, Geon Kook Lee et al.
Cancers 2023, 15(18), 4460; https://doi.org/10.3390/cancers15184460
Available online: https://www.mdpi.com/2072-6694/15/18/4460

“The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy”
by Erkan Topkan, Ugur Selek, Berrin Pehlivan, Ahmet Kucuk, Duriye Ozturk, Beyza Sirin Ozdemir, Ali Ayberk Besen and Huseyin Mertsoylu
Cancers 2023, 15(18), 4512; https://doi.org/10.3390/cancers15184512
Available online: https://www.mdpi.com/2072-6694/15/18/4512

“Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations”
by Johnathan Arnon, Michael Tabi, Yakir Rottenberg, Aviad Zick, Philip Blumenfeld, Tamar Hamburger, Eli Pikarsky, Eti Avraham, Leeby Levine, Aron Popovtzer et al.
Cancers 2023, 15(19), 4733; https://doi.org/10.3390/cancers15194733
Available online: https://www.mdpi.com/2072-6694/15/19/4733

“Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy”
by Magdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda, Anna Janowicz-Żebrowska, Aleksandra Piórek, Magdalena Knetki-Wróblewska, Piotr Jaśkiewicz, Adam Płużański et al.
Cancers 2023, 15(4), 1277; https://doi.org/10.3390/cancers15041277
Available online: https://www.mdpi.com/2072-6694/15/4/1277

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of NK cell-based cancer immunotherapy, which are listed below:

1. “The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies”
by Maria G. Desimio, Daniela A. Covino, Beatrice Rivalta, Caterina Cancrini and Margherita Doria
Cancers 2023, 15(6), 1914; https://doi.org/10.3390/cancers15061914
Available online: https://www.mdpi.com/2072-6694/15/6/1914

2. “Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment”
by Rossella Paolini and Rosa Molfetta
Cancers 2023, 15(18), 4616; https://doi.org/10.3390/cancers15184616
Available online: https://www.mdpi.com/2072-6694/15/18/4616 

3. “Co-Expression of an IL-15 Superagonist Facilitates Self-Enrichment of GD₂-Targeted CAR-NK Cells and Mediates Potent Cell Killing in the Absence of IL-2”
by Malena Bodden, Aline Häcker, Jasmin Röder, Anne Kiefer, Congcong Zhang, Anita Bhatti, Jordi Pfeifer Serrahima, Evelyn Ullrich, Ines Kühnel and Winfried S. Wels
Cancers 2023, 15(17), 4310; https://doi.org/10.3390/cancers15174310
Available online: https://www.mdpi.com/2072-6694/15/17/4310

4. “CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)”
by Juliette Nowak, Marco Bentele, Ivana Kutle, Katharina Zimmermann, Jonathan Lukas Lühmann, Doris Steinemann, Stephan Kloess, Ulrike Koehl, Willi Roßberg, Amed Ahmed et al.
Cancers 2023, 15(12), 3169; https://doi.org/10.3390/cancers15123169
Available online: https://www.mdpi.com/2072-6694/15/12/3169 

5. “A Subset of PD-1-Expressing CD56^bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer”
by Marta Gascón-Ruiz, Ariel Ramírez-Labrada, Rodrigo Lastra, Luis Martínez-Lostao, J. Ramón Paño-Pardo, Andrea Sesma, María Zapata-García, Alba Moratiel, Elisa Quílez, Irene Torres-Ramón et al.
Cancers 2023, 15(2), 329; https://doi.org/10.3390/cancers15020329
Available online: https://www.mdpi.com/2072-6694/15/2/329 

6. “Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer Patients”
by Elin Bernson, Oisín Huhn, Veronika Karlsson, Delia Hawkes, Maria Lycke, Valentina Cazzetta, Joanna Mikulak, James Hall, Anna M. Piskorz, Rosalba Portuesi et al.
Cancers 2023, 15(13), 3362; https://doi.org/10.3390/cancers15133362
Available online: https://www.mdpi.com/2072-6694/15/13/3362

7. “Plasmacytoid Dendritic Cell, Slan⁺-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients”
by Francesca Pettinella, Chiara Lattanzi, Marta Donini, Elena Caveggion, Olivia Marini, Giulia Iannoto, Sara Costa, Elena Zenaro, Tiago Moderno Fortunato, Sara Gasperini et al.
Cancers 2023, 15(21), 5285; https://doi.org/10.3390/cancers15215285
Available online: https://www.mdpi.com/2072-6694/15/21/5285 

8. “Natural Killer T Cell Diversity and Immunotherapy”
by Eduardo I. Tognarelli, Cristián Gutiérrez-Vera, Pablo A. Palacios, Ignacio A. Pasten-Ferrada, Fernanda Aguirre-Muñoz, Daniel A. Cornejo, Pablo A. González and Leandro J. Carreño
Cancers 2023, 15(24), 5737; https://doi.org/10.3390/cancers15245737
Available online: https://www.mdpi.com/2072-6694/15/24/5737 

9. “Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer”
by Fernán Gómez-Valenzuela, Ignacio Wichmann, Felipe Suárez, Sumie Kato, Enrique Ossandón, Marcela Hermoso, Elmer A. Fernández and Mauricio A. Cuello
Cancers 2023, 16(1), 80; https://doi.org/10.3390/cancers16010080
Available online: https://www.mdpi.com/2072-6694/16/1/80

10. “Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant”
by Catherine C. Coombs, Saumya Easaw, Natalie S. Grover and Susan M. O’Brien
Cancers 2023, 15(6), 1838; https://doi.org/10.3390/cancers15061838
Available online: https://www.mdpi.com/2072-6694/15/6/1838

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office